Physician profile
Joseph Steinberg
NPI 1659367209
$9,262.01
in general payments reported to CMS, 2019-2025
43 companies · $4,991 in 2025
The $4,991 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $56.37 · 2021: $85.67 · 2022: $695 · 2023: $2,571 · 2024: $670 · 2025: $4,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Food and Beverage: $2,748 · Travel and Lodging: $802 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Food and Beverage | $2,748.19 |
| Travel and Lodging | $801.54 |
| Education | $182.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $4,886.58 | 2022-2025 | |
| Angiodynamics, INC. | $1,971.24 | 2023-2024 | Nanoknife |
| Sumitomo Pharma America, INC. | $346.88 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $340.90 | 2019-2023 | Veozah, Myrbetriq |
| Procept Biorobotics Corporation | $193.62 | 2022-2023 | Aquabeam Robotic System |
| Abbvie INC. | $125.44 | 2022-2025 | Lupron Depot |
| Medtronic, INC. | $125.00 | 2024 | Interstim |
| Myovant Sciences INC. | $104.00 | 2021-2022 | |
| Urogen Pharma, INC. | $98.96 | 2022-2025 | Jelmyto |
| Telix Pharmaceuticals | $85.37 | 2024-2025 | Illuccix |
| Janssen Biotech, INC. | $80.88 | 2019-2023 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $70.88 | 2019-2024 | |
| Urovant Sciences INC | $70.83 | 2022 | |
| Coloplast Corp | $65.80 | 2023-2025 | Speedicath |
| Boston Scientific Corporation | $47.09 | 2020-2023 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agiliti Surgical, INC. | $46.85 | 2023 | Trinity, Sonablate |
| Becton, Dickinson and Company | $43.91 | 2024 | Channel Drain |
| Mimedx Group, INC. | $39.68 | 2024-2025 | |
| 180 Medical, INC. | $36.17 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Endo USA, INC. | $34.86 | 2024-2025 | Xiaflex, Aveed |
| Ethicon US, LLC | $34.76 | 2025 | Echelon Flex |
| Myriad Genetic Laboratories, INC. | $32.65 | 2022 | |
| Endo Pharmaceuticals INC. | $30.88 | 2022-2023 | Xiaflex, Aveed |
| E.R. Squibb & Sons, L.L.C. | $28.83 | 2019-2023 | Opdivo |
| Ferring Pharmaceuticals INC. | $27.87 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $25.50 | 2023 | Seglentis |
| Tolmar, INC. | $18.92 | 2024 | |
| Immunitybio, INC. | $18.86 | 2025 | |
| Intuitive Surgical, INC. | $18.36 | 2023 | Da Vinci Surgical System |
| Photocure INC | $16.37 | 2024 | Cysview |
| Olympus America INC. | $16.28 | 2025 | Itind System |
| C. R. Bard, INC. & Subsidiaries | $16.16 | 2025 | Bard Urinary Drainage Bag |
| Abc Home Medical Supply, INC. | $15.54 | 2025 | |
| Merck Sharp & Dohme LLC | $14.99 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $14.68 | 2020 | |
| Glaxosmithkline, LLC. | $14.58 | 2022 | |
| Zyla Life Sciences, INC. | $14.33 | 2019 | |
| Pfizer INC. | $13.83 | 2023 | |
| Avation Medical, INC. | $13.42 | 2024 | Vivally |
| Bioprotect Medical, INC. | $13.18 | 2024 | Bioprotect Balloon Implant System |
| Eisai INC. | $10.83 | 2019 | |
| Travere Therapeutics, INC. | $1.19 | 2024 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.